ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1160
0.00 (0.00%)
At close: Jul 28, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $939.13 thousand as of July 29, 2026. Its market cap has decreased by -47.00% in one year.
Market Cap
939.13K
Enterprise Value
1.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
ChartMarket Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 939.13K, a decrease of -99.02%. That is a compound annual growth rate of -64.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 939.13K | -13.17% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abpro Holdings | 1.21M |
| AXIM Biotechnologies | 1.09M |
| Nymox Pharmaceutical | 1.06M |
| Evofem Biosciences | 1.00M |
| Avenue Therapeutics | 988.49K |
| Regenerative Medical Technology Group | 919.73K |
| Lyra Therapeutics | 887.44K |
| Agentix | 801.34K |